Literature DB >> 33868558

Mechanical Thrombectomy for Sequential Bilateral Middle Cerebral Artery Occlusions in a Patient With Recurrent Cryptogenic Strokes: A Case Report.

Matthew J Kercher1, Dinesh Ramanathan1, Brian C Dahlin1, Alan H Yee2, Jared W Clouse1, Ben Waldau1.   

Abstract

Recurrent sequential mechanical thrombectomy for cryptogenic large vessel occlusion (LVO) can lead to excellent clinical outcome. A 68-year-old right-handed male presented with an acute proximal right middle cerebral artery (MCA) ischemic syndrome and underwent successful revascularization by mechanical thrombectomy with normal functional recovery. He was treated with dual antiplatelet therapy for 2 months following discharge, however later discontinued clopidogrel due to side effects. He then developed a recurrent, contralateral MCA occlusion 16 months later and once again received emergent endovascular reperfusion therapy with excellent neurological outcome. He has remained on off-label empiric oral anticoagulation since and has not had recurrent stroke nor evidence of cerebral ischemia. Favorable clinical outcomes can be achieved in patients despite recurrent LVO who underwent emergent mechanical thrombectomy. Optimal antithrombotic secondary stroke prevention strategies following embolic stroke of unknown source remains uncertain as recent evidence does not support rivaroxaban or dabigatran over aspirin. The benefit of apixaban over aspirin for the prevention of recurrent cerebral ischemia is under current investigation.
© The Author(s) 2020.

Entities:  

Keywords:  intracranial arterial diseases; neuroradiology; neurosurgery; outcomes; stroke

Year:  2020        PMID: 33868558      PMCID: PMC8022181          DOI: 10.1177/1941874420934333

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  17 in total

1.  Embolic stroke of unknown source (ESUS) in young patients.

Authors:  Filipa Ladeira; Raquel Barbosa; André Caetano; Marcelo D Mendonça; Sofia Calado; Miguel Viana-Baptista
Journal:  Int J Stroke       Date:  2015-10       Impact factor: 5.266

2.  Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions.

Authors:  B I Lee; H S Nam; J H Heo; D I Kim
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

Review 3.  Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.

Authors:  Robert G Hart; Luciana Catanese; Kanjana S Perera; George Ntaios; Stuart J Connolly
Journal:  Stroke       Date:  2017-03-06       Impact factor: 7.914

4.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

Authors:  Yongjun Wang; Yilong Wang; Xingquan Zhao; Liping Liu; David Wang; Chunxue Wang; Chen Wang; Hao Li; Xia Meng; Liying Cui; Jianping Jia; Qiang Dong; Anding Xu; Jinsheng Zeng; Yansheng Li; Zhimin Wang; Haiqin Xia; S Claiborne Johnston
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

5.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.

Authors:  Hooman Kamel; W T Longstreth; David L Tirschwell; Richard A Kronmal; Joseph P Broderick; Yuko Y Palesch; Caitlyn Meinzer; Catherine Dillon; Irene Ewing; Judith A Spilker; Marco R Di Tullio; Eldad A Hod; Elsayed Z Soliman; Seemant Chaturvedi; Claudia S Moy; Scott Janis; Mitchell Sv Elkind
Journal:  Int J Stroke       Date:  2018-09-10       Impact factor: 5.266

6.  Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).

Authors:  Hans-Christoph Diener; J Donald Easton; Christopher B Granger; Lisa Cronin; Christine Duffy; Daniel Cotton; Martina Brueckmann; Ralph L Sacco
Journal:  Int J Stroke       Date:  2015-09-30       Impact factor: 5.266

7.  Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Authors:  Hans-Christoph Diener; Ralph L Sacco; J Donald Easton; Christopher B Granger; Richard A Bernstein; Shinichiro Uchiyama; Jörg Kreuzer; Lisa Cronin; Daniel Cotton; Claudia Grauer; Martina Brueckmann; Marina Chernyatina; Geoffrey Donnan; José M Ferro; Martin Grond; Bernd Kallmünzer; Jerzy Krupinski; Byung-Chul Lee; Robin Lemmens; Jaime Masjuan; Miroslav Odinak; Jeffrey L Saver; Peter D Schellinger; Danilo Toni; Kazunori Toyoda
Journal:  N Engl J Med       Date:  2019-05-16       Impact factor: 91.245

8.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245

9.  Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register.

Authors:  K M Mohan; S L Crichton; A P Grieve; A G Rudd; C D A Wolfe; P U Heuschmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05-21       Impact factor: 10.154

10.  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-03-14       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.